# TITRE III: Influenza B Immunogenicity Investigation

> **NCT03753347** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **British Columbia Centre for Disease Control** · enrollment: 55 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** 2018-19 quadrivalent inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT03753347
- **Lead sponsor:** British Columbia Centre for Disease Control
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-01
- **Primary completion:** 2019-04-12
- **Final completion:** 2025-06-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03753347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03753347, "TITRE III: Influenza B Immunogenicity Investigation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03753347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*